CMT4F

PRX | 2001

What Is CMT4F?

CMT4F is a type of CMT caused by mutations in the PRX gene. This gene provides instructions for producing periaxin, a protein that plays an important role in maintaining the structure and stability of the myelin sheath in peripheral nerves. Mutations in the PRX gene disrupt normal Schwann cell function and myelin maintenance, leading to impaired nerve signal transmission.

CMT4F is autosomal recessive, meaning that both of the gene’s copies must have a CMT-causing mutation to cause this subtype.

Clinical Features

Symptom onset in CMT4F is variable, ranging from early childhood to mid-adulthood. Symptoms usually begin in the lower limbs and progress to the upper body. Vocal fold paresis has been reported. Nerve conduction studies usually show slowed conduction velocities and somewhat reduced amplitudes, consistent with a demyelinating form of CMT.

CMT4F symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • A steppage-style walking pattern
  • Reduced sensation
  • Reduced or absent reflexes
  • Foot deformities, including high arches and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Vocal fold paresis (some patients)
  • Motor development delay
  • Additional symptoms not listed here

Disease Course

CMT4F shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression can be rapid but is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMT4F

Classification
CMT4

Neuropathy Type
Demyelinating

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
PRX

Gene Full Name
periaxin

HGNC Gene Alias(es)
KIAA1620

Chromosome
19q13.2

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Mitochondrial Involvement
No

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
High

Prediction:
Periaxin anchors the Schwann cell to its basal lamina through the DRP2 and dystroglycan complex that shapes Cajal bands, and the literature predicts that truncating PRX variants on both alleles simply take it away. Prx-null mice lose those appositions, myelinate over abnormally short internodes, and develop demyelination with marked sensory abnormality, matching the prominent sensory loss that sets affected patients apart from typical CMT1.

Rationale:
The lesion here is architectural: with no periaxin the abaxonal cytoplasmic channels collapse, internodal length is set wrong from the start, and sensory fibers suffer disproportionately. Nonsense and frameshift alleles predominate, so no mutant periaxin persists in the sheath to act on anything.

ClinVar Pathogenic Variants

View PRX ClinVar Variants

CMT4F OMIM Entry

CMT4F OMIM

PRX OMIM Entry

PRX OMIM

More Info

CMT4F Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

A Mutation in Periaxin is Responsible for CMT4F, an Autosomal Recessive form of Charcot-Marie-Tooth Disease

Authors

Guilbot, A., Williams, A., Ravisé, N., Verny, C., Brice, A., Sherman, D. L., Brophy, P. J., LeGuern, E., Delague, V., Bareil, C., Mégarbané, A., & Claustres, M.

Publication Date
February 15, 2001

Updated: May 9, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.